Anti-GPATCH2L monoclonal antibody

Pre-made anti-GPATCH2L monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to GPATCH2L/GPATCH2L products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0925-Ab-1/ GM-Tg-hg-IP0925-Ab-2Anti-Human GPATCH2L monoclonal antibodyHuman
GM-Tg-rg-IP0925-Ab-1/ GM-Tg-rg-IP0925-Ab-2Anti-Rat GPATCH2L monoclonal antibodyRat
GM-Tg-mg-IP0925-Ab-1/ GM-Tg-mg-IP0925-Ab-2Anti-Mouse GPATCH2L monoclonal antibodyMouse
GM-Tg-cynog-IP0925-Ab-1/ GM-Tg-cynog-IP0925-Ab-2Anti-Cynomolgus/ Rhesus macaque GPATCH2L monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0925-Ab-1/ GM-Tg-felg-IP0925-Ab-2Anti-Feline GPATCH2L monoclonal antibodyFeline
GM-Tg-cang-IP0925-Ab-1/ GM-Tg-cang-IP0925-Ab-2Anti-Canine GPATCH2L monoclonal antibodyCanine
GM-Tg-bovg-IP0925-Ab-1/ GM-Tg-bovg-IP0925-Ab-2Anti-Bovine GPATCH2L monoclonal antibodyBovine
GM-Tg-equg-IP0925-Ab-1/ GM-Tg-equg-IP0925-Ab-2Anti-Equine GPATCH2L monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0925-Ab-1/ GM-Tg-hg-IP0925-Ab-2; GM-Tg-rg-IP0925-Ab-1/ GM-Tg-rg-IP0925-Ab-2;
GM-Tg-mg-IP0925-Ab-1/ GM-Tg-mg-IP0925-Ab-2; GM-Tg-cynog-IP0925-Ab-1/ GM-Tg-cynog-IP0925-Ab-2;
GM-Tg-felg-IP0925-Ab-1/ GM-Tg-felg-IP0925-Ab-2; GM-Tg-cang-IP0925-Ab-1/ GM-Tg-cang-IP0925-Ab-2;
GM-Tg-bovg-IP0925-Ab-1/ GM-Tg-bovg-IP0925-Ab-2; GM-Tg-equg-IP0925-Ab-1/ GM-Tg-equg-IP0925-Ab-2
Products NameAnti-GPATCH2L monoclonal antibody
Formatmab
Target NameGPATCH2L
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-GPATCH2L monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0925-Ag-1Recombinant multi-species GPT2L/ GPATCH2L/ C14orf118 protein


    Target information

    Target IDGM-IP0925
    Target NameGPATCH2L
    Gene ID55668,70373,314325,703697,480397,101098961,509393,100051827
    Gene Symbol and Synonyms1700020O03Rik,4732487G21Rik,A630090I05Rik,C10H14orf118,C14orf118,C8H14orf118,GPATCH2L,Kiaa1152,RGD1308907
    Uniprot AccessionQ9NWQ4
    Uniprot Entry NameGPT2L_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000089916
    Target ClassificationN/A

    The target: GPATCH2L, gene name: GPATCH2L, also named as C14orf118. .



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.